In addition, Zhou and colleagues demonstrated that PVT1 could be enriched by enhancer of zeste homolog 2 (EZH2) [31], a marker of an advanced metastatic disease in numerous types of cancer including ATC [91–94], which may also contribute to the regulation of TSHR expression [31]. The gene discussed is EZH2; the disease is cancer.